Sotac Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
Sotac Pharmaceuticals has a total shareholder equity of ₹493.3M and total debt of ₹248.6M, which brings its debt-to-equity ratio to 50.4%. Its total assets and total liabilities are ₹1.1B and ₹560.0M respectively. Sotac Pharmaceuticals's EBIT is ₹59.0M making its interest coverage ratio 3.5. It has cash and short-term investments of ₹34.2M.
Key information
50.4%
Debt to equity ratio
₹248.59m
Debt
Interest coverage ratio | 3.5x |
Cash | ₹34.18m |
Equity | ₹493.29m |
Total liabilities | ₹559.98m |
Total assets | ₹1.05b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: SOTAC's short term assets (₹606.5M) exceed its short term liabilities (₹437.3M).
Long Term Liabilities: SOTAC's short term assets (₹606.5M) exceed its long term liabilities (₹122.7M).
Debt to Equity History and Analysis
Debt Level: SOTAC's net debt to equity ratio (43.5%) is considered high.
Reducing Debt: Insufficient data to determine if SOTAC's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: SOTAC's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: SOTAC's interest payments on its debt are well covered by EBIT (3.5x coverage).